Pavan Cheruvu
Patrimonio netto: 2 M $ in data 31/05/2026
Patrimonio netto: 2 M $ in data 31/05/2026
Pavan K.
Cheruvu is currently Chief Executive Officer & Director at Amanat Acquisition Corp.
Former positions include Chief Executive Officer at Sio Gene Therapies, Inc. from 2018 to 2018, Chief Executive Officer at Axovant Sciences, Inc. from 2018 to 2020, and President, Chief Executive Officer & Director at Bitterroot Bio, Inc. Education includes undergraduate studies at Duke University, graduate studies at the University of Oxford, and a doctorate from Harvard Medical School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
6,9% | 20/05/2026 | 150.000 ( 6,9% ) | 2 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|
| Società | Posizione | Fine |
|---|---|---|
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Amministratore Delegato | 01/02/2026 |
| SIO GENE THERAPIES INC. | Amministratore Delegato | 31/01/2022 |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Amministratore Delegato | 01/12/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. BiotechnologyHealth Technology Engages in research and development of cardio vascular diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale